Difference between revisions of "Amyloid beta A4 peptide"

From MyMediaWiki
Jump to: navigation, search
(New page: {{subst:infobox}})
 
m
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''  
+
! {infobox header}| '''{{PAGENAME}}'''  
 
|-
 
|-
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]  
+
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:Beta_amyloid.JPG|200px|{{PAGENAME}}]]  
 
|-
 
|-
 
| Substrate peptide name
 
| Substrate peptide name
Line 9: Line 8:
 
|-
 
|-
 
| Synonyms
 
| Synonyms
| -
+
| Alzheimer disease amyloid protein
 
|-
 
|-
 
| Determination type
 
| Determination type
| In situ
+
| In vitro
 
|-
 
|-
 
| Source
 
| Source
Line 18: Line 17:
 
|-
 
|-
 
| Subcellular localization
 
| Subcellular localization
| Cytoskeleton
+
| Extracellular; cerebrospinal fluid
 +
Alzheimer's disease neuritic plaques
 +
 
 
|-
 
|-
 
| Swissprot ID
 
| Swissprot ID
| [http://au.expasy.org/uniprot/P08865 P08865]
+
| [http://au.expasy.org/uniprot/P05067 P05067]
 
|-
 
|-
 
| Reactive glutamines
 
| Reactive glutamines
| [[Q41 (Actin)|Q41]]
+
| [[TG2 reactive residues (APP)|Q15]]
 
|-
 
|-
| Reactive lysines
+
| Reactive lysines  
| Not determined yet
+
| [[TG2 reactive residues (APP)|K16, K28]]
 
|-
 
|-
 
| Substrate sequence
 
| Substrate sequence
| GRPRHQGVMVG
+
| YEVHH''QK''LVFFA
 +
 
 +
DVGSN''K''GAIIG
 +
 
 
|-
 
|-
 
| Structure
 
| Structure
| [http://www.rcsb.org/pdb/explore/explore.do?structureId=2BTF 2BTF]
+
| [http://www.rcsb.org/pdb/explore/explore.do?structureId=1AML 1AML ]
 
|-
 
|-
 
| Surface accessibility
 
| Surface accessibility
| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
+
| [http://gibk21.bse.kyutech.ac.jp/asaview/all/1aml.pdf ASAView] pdf
 +
[http://gibk21.bse.kyutech.ac.jp/asaview/all/1aml.txt ASAView] txt
 
|-
 
|-
 
| Disorder prediction
 
| Disorder prediction
Line 42: Line 47:
 
|-
 
|-
 
| Reference
 
| Reference
| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=9252372&dopt=Abstract PMID:9252372]
+
| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=7905838&dopt=Abstract PMID:7905838]
 
|-
 
|-
 
| Notes
 
| Notes
 
|  
 
|  
 
|-
 
|-
| {{infobox header}} |  
+
| Video
 +
|{{#ev:dailymotion|7qzKHArw798dckRrh|300}}
 +
|-
 +
| {infobox header} |  
 
|-
 
|-
 
|}
 
|}
  
 
[[Category:Tissue transglutaminase|*]]
 
[[Category:Tissue transglutaminase|*]]

Latest revision as of 11:23, 10 March 2015

Amyloid beta A4 peptide
Amyloid beta A4 peptide
Substrate peptide name Amyloid beta A4 peptide
Synonyms Alzheimer disease amyloid protein
Determination type In vitro
Source Homo sapiens
Subcellular localization Extracellular; cerebrospinal fluid

Alzheimer's disease neuritic plaques

Swissprot ID P05067
Reactive glutamines Q15
Reactive lysines K16, K28
Substrate sequence YEVHHQKLVFFA

DVGSNKGAIIG

Structure 1AML
Surface accessibility ASAView pdf

ASAView txt

Disorder prediction IUPred
Reference PMID:7905838
Notes
Video 7qzKHArw798dckRrh|300}}